ON SATURDAY, FEBRUARY 8, 2025
We invited you to JUMP IN and FEEL THE LOVE with Us at our 19th Annual Valentine Plunge! And you did!! Together we raised over $450,000 to help support our pALS! You are an amazing group of individuals set out to make the world a better place by supporting this cause and changing the lives of our pALS!
THANK YOU FROM THE BOTTOM OF OUR HEARTS!!
About the Valentine Plunge
The plunge is an exciting fundraising event where participants, called Plungers, collect donations for ALS patients in exchange for plunging into the icy Atlantic Ocean.
Get a team together – register as an individual – be a spectator cheering on your plungers – make a donation – be part of an amazing fundraising event! We’d like to give many, many thanks to all who have participated in the past years and now! Let’s make history again this February 2025!
Thank you again to all of our supporters!
Working together, we can accomplish anything!
Use the hashtags #valentineplunge and #valentineplunge2025
Post your video or pictures to your team page
FOLLOW US
Working together, we can accomplish anything!
Use the hashtags #valentineplunge and #valentineplunge2025
Post your video or pictures to your team page
FOLLOW US
Facebook Posts
Daily treatment with IPL344 for up to three years was safe and appeared to slow amyotrophic lateral sclerosis (ALS) progression, according to recently published data from a small Phase 2a clinical trial.![]()
![]()
Patients undergoing treatment gained weight and experienced slower declines in functional abilities and lung function. The treatment also lengthened survival in patients, compared with external placebo groups.![]()
![]()
The majority of patients tolerated the drug well, and none discontinued treatment due to safety concerns.![]()
![]()
The findings were published in the study, “Akt Activation With IPL344 Treatment for Amyotrophic Lateral Sclerosis: First in Human, Open-Label Study,” in the journal Muscle & Nerve. The work was supported by the therapy’s developer Immunity Pharma, which is planning a large, placebo-controlled trial to further assess IPL344’s safety and efficacy in ALS.![]()
![]()
alsnewstoday.com/news/ipl344-slows-als-progression-trial-data-suggest/
The sound of the bagpipes each year to kick things off…If you know, you know!
And a big THANK YOU
to all of our sponsors who support our mission each year!!
Donate directly to the Joan Dancy & pALS Foundation at Hackensack Meridian Health Riverview Medical Center, One Riverview Plaza, P. O. Box 8157, Red Bank, NJ 07701
The Joan Dancy & pALS Foundation was formed in 2005 by Terry Magovern in honor of Joan Dancy, his late fiancé, after she succumbed to ALS. Our mission is to help people in our local communities afflicted with ALS by providing a better quality of life for them and their families.
